Article
Somatic mutations of the mixed-lineage leukemia 3 (MLL3) gene in primary breast cancers.
Pathology oncology research : POR - 1 Jun 2011
Wang Xin-Xin, Fu Liya, Li Xuan, Wu Xiao, Zhu Zhengmao, Fu Li, Dong Jin-Tang
Abstract excerpt
The mixed-lineage leukemia 3 (MLL3) gene, which encodes an important component of a histone H3 lysine 4 methyltransferase complex named the ASC-2- and Mll3-containing complex (ASCOM), has been implicated as a tumor suppressor gene due to its frequent mutations in multiple types of human tumors as well as tumor induction upon targeted inactivation of the gene in mice. The role of MLL3 in breast cancer, however,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
